RSS   Newsletter   Contact   Advertise with us

Cesca announces change in executive leadership

Share on Twitter Share on LinkedIn
Staff writer | Rancho Cordova, Ca., USA | October 30, 2014
CescaOctober 30, 2014, Rancho Cordova, Ca., USA - Cesca Therapeutics Inc., an autologous cell-based regenerative medicine company, announced that Robin C. Stracey will serve as interim CEO pending the new hire.
Mr. Stracey was appointed to the Board of Directors in July 2011. He has been the President and Chief Executive Officer at both publicly-traded and privately held companies in the life sciences sector, including Integrated Fluidics, Inc., Cantimer Incorporated, and Applied Imaging Corporation.

Mr. Stracey has also held senior executive positions at Thermo Electron Corporation, now Thermo Fisher Scientific, and Dade Behring Inc., now Siemens Healthcare.

He has a B.S. degree with honors from the University of Nottingham in the United Kingdom. He will maintain offices in each of Cesca’s Rancho Cordova and Emeryville facilities.